Compare DSP Healthcare Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.01
2.23
NAV
₹49.35
₹380.34
Fund Started
12 Nov 2018
01 Aug 2005
Fund Size
₹3514.02 Cr
₹1307.98 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 30 days.
1 Year
10.33%
13.36%
3 Year
20.99%
25.08%
5 Year
14.73%
14.62%
Equity
92.30%
95.05%
Cash
7.70%
4.95%
Top 10 Holdings
Cipla Ltd. | 8.35% |
Ipca Laboratories Ltd. | 8.21% |
Sun Pharmaceutical Industries Ltd. | 8.14% |
Illumina Inc. (USA) | 7.59% |
Sai Life Sciences Ltd. | 6.88% |
Gland Pharma Ltd. | 6.54% |
Globus Medical Inc | 5.72% |
Apollo Hospitals Enterprise Ltd. | 4.81% |
Cohance Lifesciences Ltd. | 4.13% |
Vijaya Diagnostic Centre Ltd. | 3.60% |
Sun Pharmaceutical Industries Ltd. | 8.54% |
Ajanta Pharma Ltd. | 5.08% |
Divi's Laboratories Ltd. | 4.74% |
Gland Pharma Ltd. | 4.11% |
Caplin Point Laboratories Ltd. | 4.02% |
Lupin Ltd. | 3.77% |
Apollo Hospitals Enterprise Ltd. | 3.52% |
Alkem Laboratories Ltd. | 3.14% |
Dr. Reddy's Laboratories Ltd. | 3.01% |
Max Healthcare Institute Ltd. | 2.98% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
12 Nov 2018
01 Aug 2005
